IL-18 expression and functional activity has been identified in several aut
oimmune and infectious diseases. To clarify the potential role of IL-18 dur
ing early innate immune responses, we have explored the capacity of IL-18 t
o activate neutrophils. Human peripheral blood-derived neutrophils constitu
tively expressed IL-18R (alpha and beta) commensurate with the capacity to
rapidly respond to IL-18. IL-18 induced cytokine and chemokine release from
neutrophils that was protein synthesis dependent, upregulated CD11b expres
sion, induced granule release, and enhanced the respiratory burst following
exposure to fMLP, but had no effect upon the rate of neutrophil apoptosis.
The capacity to release cytokine and chemokine was significantly enhanced
in neutrophils derived from rheumatoid arthritis synovial fluid, indicating
differential responsiveness to IL-18 dependent upon prior neutrophil activ
ation in vivo. Finally, IL-18 administration promoted neutrophil accumulati
on in vivo, whereas IL-18 neutralization suppressed the severity of footpad
inflammation following carrageenan injection. The latter was accompanied b
y reduction in tissue myeloperoxidase expression and suppressed local TNF-a
lpha production. Together, these data define a novel role for IL-18 in acti
vating neutrophils and thereby promoting early innate immune responses.